Flexion Therapeutics, Inc. FLXN Balance Sheet

Flexion therapeutics, inc. (FLXN)

Balance Sheet / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13
Assets
Current assets
Cash and cash equivalents
112,019	82,253	87,769	45,701	87,935	87,229	117,766	174,565	147,304	127,789	159,179	197,179	42,921	30,915	66,809	119,010	58,903	62,944	73,507	28,339	26,963	103,097	14,365	12,015	35,789	16,188
Marketable securities
13,200	54,400	88,000	125,811	129,913	171,600	185,094	165,832	224,338	264,589	175,921	162,680	142,896	174,688	92,693	44,251	39,456	48,302	58,658	99,035	105,381	48,527	52,223	59,976	42,723	250
Accounts receivable, net
30,362	37,115	29,316	22,589	15,130	13,121	8,798	5,060	2,397	410	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventories
19,991	16,529	14,773	12,870	10,324	7,637	5,076	3,374	2,525	1,799	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts receivable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	101	56	95	46	199	403	-	-	-	-	-
Prepaid expenses and other current assets
5,812	5,371	5,235	4,213	4,656	5,500	4,676	3,007	4,023	3,403	3,609	2,334	4,307	3,790	1,584	1,180	1,217	760	802	1,220	1,489	485	710	684	845	181
Total current assets
181,396	195,675	225,084	211,184	247,958	285,042	321,410	351,838	380,587	397,990	338,709	362,193	190,124	209,393	161,086	164,542	99,632	112,102	133,014	128,795	134,237	152,110	67,298	72,676	79,357	16,620
Property and equipment, net
15,364	13,662	10,651	9,753	10,329	10,710	10,285	10,690	10,964	11,189	11,481	11,863	11,841	11,664	11,223	11,286	9,083	7,442	4,153	2,888	1,663	1,109	681	387	392	375
Long-term investments
-	-	-	5,050	-	-	-	-	4,938	31,538	-	-	1,728	4,725	2,003	-	3,006	7,357	-	-	-	-	-	-	-	-
Right-of-use assets
7,822	8,223	8,618	6,493	6,332	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Marketable securities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	5,016	-	-	-	-	-
Deferred offering costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,623
Other assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	30	90	270	155	-	-	-	-	16	20	24	28
Restricted cash
-	-	-	-	-	-	-	-	600	600	600	600	600	480	80	80	80	80	80	104	104	128	128	128	128	128
Total assets
204,582	217,560	244,353	232,480	264,619	295,752	331,695	362,528	397,089	441,317	350,790	374,656	204,293	226,262	174,422	175,998	112,071	127,138	137,248	131,787	141,021	153,347	68,125	73,212	79,903	18,775
Liabilities and Stockholders’ Deficit
Current liabilities
Accounts payable
11,458	15,258	12,088	11,084	11,007	12,340	8,657	5,672	3,420	6,222	3,960	2,741	2,210	2,161	2,029	3,513	3,083	3,692	1,917	1,283	2,183	1,584	1,498	964	1,783	1,279
Accrued expenses and other current liabilities
20,635	19,610	24,419	14,739	15,785	14,310	17,588	11,640	11,060	14,383	12,276	7,097	5,815	6,245	3,724	3,052	4,792	4,366	4,668	4,831	1,975	3,213	2,696	1,482	1,599	2,256
Operating lease liabilities
1,381	1,351	1,283	1,247	1,142	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Current portion of long-term debt
2,200	-	-	-	11,280	9,967	9,967	9,967	9,967	9,967	9,967	9,967	9,967	9,134	6,634	1,634	384	-	-	-	-	1,983	2,000	2,000	2,000	1,500
Total current liabilities
35,696	36,219	37,790	27,070	39,214	36,617	36,212	27,279	24,447	30,572	26,203	19,805	17,992	17,540	12,387	8,199	8,259	8,058	6,585	6,114	4,159	6,782	6,195	4,446	5,383	5,036
Long-term operating lease liability, net
7,162	7,609	7,865	5,686	5,639	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Long-term debt, net
58,060	40,176	40,070	8,956	-	3,640	5,964	8,288	10,612	12,936	15,260	17,584	19,908	21,399	23,664	13,520	14,688	15,002	14,942	-	-	1,580	2,081	2,570	3,058	3,546
2024 convertible notes, net
155,675	153,413	151,204	149,046	146,939	144,879	142,868	140,902	138,983	137,107	135,275	133,484	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other long-term liabilities
295	251	251	251	251	537	546	552	440	428	399	404	294	291	339	253	222	91	13	13	28	43	56	68	80	90
Total liabilities
256,888	237,668	237,180	191,009	192,043	185,673	185,590	177,021	174,482	181,043	177,137	171,277	38,194	39,230	36,390	21,972	23,169	23,152	21,541	6,128	4,187	8,405	8,333	7,085	8,522	8,673
Commitments and contingencies
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Preferred stock, $0.001 par value; 10,000,000 shares authorized at March 31, 2020 and December 31, 2019 and 0 shares issued and outstanding at March 31, 2020 and December 31, 2019
0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders' deficit
Common stock, $0.001 par value; 100,000,000 shares authorized; 38,562,422 and 38,361,476 shares issued and outstanding, at March 31, 2020 and December 31, 2019, respectively
39	38	38	38	38	38	38	38	38	38	32	32	32	32	28	28	22	21	21	21	21	21	15	15	15	0
Additional paid-in capital
653,050	648,391	642,087	638,054	632,797	628,944	624,475	620,390	613,881	609,810	472,322	467,874	401,694	398,757	326,605	324,780	245,495	243,853	241,905	240,731	239,447	238,402	145,446	144,744	144,069	1,458
Accumulated other comprehensive income
6	62	131	230	105	-77	-157	-310	-576	-407	-62	-77	-62	-71	-27	10	-8	-96	2	-6	15	-5	0	3	0	-0
Accumulated deficit
-705,401	-668,599	-635,083	-596,851	-560,364	-518,826	-478,251	-434,611	-390,736	-349,167	-298,639	-264,450	-235,565	-211,686	-188,574	-170,792	-156,607	-139,792	-126,223	-115,086	-102,650	-93,476	-85,671	-78,636	-72,705	-66,163
Total stockholders' deficit
-52,306	-20,108	7,173	41,471	72,576	110,079	146,105	185,507	222,607	260,274	173,653	203,379	166,099	187,032	138,032	154,026	88,902	103,986	115,706	125,659	136,833	144,941	59,791	66,127	71,380	-64,703
Total liabilities and stockholders' deficit
204,582	217,560	244,353	232,480	264,619	295,752	331,695	362,528	397,089	441,317	350,790	374,656	204,293	226,262	174,422	175,998	112,071	127,138	137,248	131,787	141,021	153,347	68,125	73,212	79,903	18,775